Gene therapy can cure disease by replacing a faulty gene or adding a new gene in body's cell of patient. However, there is some potential risks of this technique such as unwanted immune reaction, targeting the wrong cells, infection caused by the virus and the possibility of causing a tumor. So it is critical to perform detailed preclinical and clinical trials even though it can take many years. CD BioSciences is dedicated to providing tailored clinical studies depending on the characteristics of clients' product to speed up its availability.
Explore Our Clinical Services to Facilitate Your Gene Therapy Program
CD BioSciences is specialized in the design, execution and delivery clinical studies with a focus on gene therapy. We provide adequate studies to assess the feasibility and risks of the gene therapy products. The detailed clinical studies include:
Moreover, by collecting and analyzing insights from patients and their families, disease communities and advocates, CD BioSciences provides long term monitoring of patients who have been treated with a gene therapy and gives long term efficacy and safety follow up.
CD BioSciences is dedicated to providing tailored services to help our clients overcome the difficulties in the clinical trials and speed up the gene therapy development process. If you want to get more information about our service, please feel free to contact us to discuss how can we move us forward together on the journey of getting your gene therapy product to market.